Stay updated on HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page.

Latest updates to the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page
- Check5 days agoChange DetectedAdded Tianjin Municipality as a new study location and updated the location section. The old 'Tianjin Municipality Locations' entry was removed and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe Publications section now notes that listed publications are auto-filled from PubMed and may not pertain to the study. The footer revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check41 days agoChange DetectedA government funding and operating status notice at the top of the page has been removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedThe new screenshot shows only minor visual/layout adjustments to the page without altering core study details. There are no additions or deletions to sections such as Study Overview, Eligibility Criteria, Interventions, or Outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check84 days agoChange DetectedAdd: government-operating-status notice and v3.2.0; Remove: resource topic for Autoimmune thrombocytopenic purpura and v3.1.0.SummaryDifference5%

- Check91 days agoChange DetectedAdds Revision: v3.1.0 and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and Revision: v3.0.2; overall, updates versioning and trims older topics.SummaryDifference0.7%

Stay in the know with updates to HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in ITP Patients: Safety, PK, Efficacy Clinical Trial page.